LEGEND BIOTECH CORP-ADR (LEGN)
US52490G1022 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -520.12M | -445.70M | -386.20M | -307.60M | -130.40M | |||
| Depreciation Amortization | 20.45M | 18.40M | 13.90M | 9.90M | 4.10M | |||
| Income Taxes - Deferred | -628.00K | -300.00K | -300.00K | -100.00K | N/A | |||
| Change In Working Capital | -25.13M | 201.30M | 142.00M | -11.20M | 45.90M | |||
| Interest Paid | 1.39M | 500.00K | 100.00K | 200.00K | 200.00K | |||
| Taxes Paid | -308.00K | -3.70M | -600.00K | -7.10M | 15.40M | |||
| Other non cash items | 132.15M | 25.10M | 32.10M | 86.00M | -2.60M | |||
| OPERATING CASH FLOW | -393.28M | -201.30M | -198.50M | -223.00M | -83.10M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -22.72M | -22.30M | -47.10M | -49.80M | -39.20M | |||
| Other Investing Activity | 115.51M | -54.80M | -147.90M | 25.60M | -19.50M | |||
| INVESTING CASH FLOW | 92.79M | -77.10M | -195.00M | -24.20M | -58.70M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -3.75M | -2.60M | -1.40M | -2.60M | 14.70M | |||
| Stock Issued/Repurchased | 795.25M | 380.60M | 628.10M | 624.00M | N/A | |||
| Other Financing Activity | N/A | 0.00 | 0.00 | -2.50M | N/A | |||
| FINANCING CASH FLOW | 791.49M | 378.00M | 626.70M | 618.90M | 14.70M | |||
| Exchange Rate Effect | 682.00K | -2.50M | 0.00 | 600.00K | 200.00K | |||
| CHANGE IN CASH | 491.68M | 97.10M | 233.20M | 372.30M | -126.90M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -393.28M | -201.30M | -198.50M | -223.00M | -83.10M | |||
| Capital Expenditure | -22.72M | -22.30M | -47.10M | -49.80M | -39.20M | |||
| FREE CASH FLOW | -416.00M | -223.60M | -245.60M | -272.80M | -122.30M | |||
All data in USD